Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?

被引：4
|
作者：
Mathew, Sanjay J. [1 ,2 ,7 ]
Jha, Manish K. [3 ,4 ]
Anand, Amit [5 ,6 ]
机构：
[1] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX USA
[2] Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, Houston, TX USA
[3] Univ Texas Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, ODonnell Brain Inst, Dallas, TX USA
[5] Mass Gen Brigham, Dept Neurol, Boston, MA USA
[6] Harvard Med Sch, Boston, MA USA
[7] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, One Baylor Pl, Houston, TX 77024 USA
来源：
JAMA PSYCHIATRY | 2023年 / 80卷 / 12期
关键词：
D O I：
10.1001/jamapsychiatry.2023.3979
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
This Viewpoint examines key issues stemming from several recent reports of electroconvulsive therapy (ECT) vs ketamine for improving depressive symptoms in treatment-resistant depression (TRD).
引用
收藏
页码：1187 / 1188
页数：2
相关论文
共 50 条
  • [11] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
  • [12] Oral ketamine for treatment-resistant depression
    Kang, Seema
    LANCET PSYCHIATRY, 2018, 5 (11): : 877 - 877
  • [13] Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression A Secondary Analysis of a Randomized Clinical Trial
    Jha, Manish Kumar
    Wilkinson, Samuel T.
    Krishnan, Kamini
    Collins, Katherine A.
    Sanacora, Gerard
    Murrough, James
    Goes, Fernando
    Altinay, Murat
    Aloysi, Amy
    Asghar-Ali, Ali
    Barnett, Brian
    Chang, Lee
    Costi, Sara
    Malone, Donald
    Nikayin, Sina
    Nissen, Steven E.
    Ostroff, Robert
    Reti, Irving
    Wolski, Kathy
    Wang, Dong
    Hu, Bo
    Mathew, Sanjay J.
    Anand, Amit
    JAMA NETWORK OPEN, 2024, 7 (06) : e2417786
  • [14] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [15] KETAMINE FOR ADOLESCENT TREATMENT-RESISTANT DEPRESSION
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S345 - S345
  • [16] SUBLINGUAL KETAMINE FOR TREATMENT-RESISTANT DEPRESSION
    Hyde, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 154 - 154
  • [17] Comparing the Effectiveness of IV Ketamine and Esketamine in a Group of Outpatients with Treatment-Resistant Depression
    Keshishyan, Anahit
    Silbersweig, Arielle
    Kim, Jonathan
    Coolidge, Sarah J.
    Tsygankova, Valeriya
    Celedon-Garcia, Rafael D.
    Richardon, Gabriel S.
    McDonald, William M.
    Kitay, Brandon M.
    Posse, Patricio Riva
    Hershenberg, Rachel
    Chatham, Anthony
    Hutchison, Charles
    Hermida, Adriana P.
    JOURNAL OF ECT, 2024, 40 (03) : E22 - E22
  • [18] Intravenous ketamine therapy in a patient with a treatment-resistant major depression
    Liebrenz, Michael
    Borgeat, Alain
    Leisinger, Ria
    Stohler, Rudolf
    SWISS MEDICAL WEEKLY, 2007, 137 (15-16) : 234 - 236
  • [19] Ketamine vs Electroconvulsive Therapy in the Management of Treatment-Resistant Depression: Do We Need More Data?
    Rhee, Taeho Greg
    Shim, Sung Ryul
    Davoudian, Pasha A.
    Espinoza, Randall T.
    Mcintyre, Roger S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2025, 86 (01)
  • [20] A Comparison of the Efficacy and Adverse Effects of Ketamine and Electroconvulsive Therapy in the Management of Treatment-Resistant Depression: A Systematic Review
    Chaudhri, Shaan I.
    Amin, Amina
    Panjiyar, Binay K.
    Al-taie, Dhuha S.
    Aledani, Esraa M.
    Gurramkonda, Jahnavi
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
12345